Analgesics Flashcards
Describe primary nociceptive afferent A and C types in terms of:
- Diameter
- Location
- Shape
Diameter
• A delta nerves have a larger diameter than C fibres
• A delta are myelinated - thus, action potentials will travel very fast through these fibres
• C fibres are non- myelinated, thus action potentials travel very slowly. C fibres tend to exist in clusters
Location
• Dorsal ganglion of spine
Shape
• Axon has two parts; peripheral axon and the central axon (goes to spinal cord)
• Peripheral axons split up into many other fibres, and are termed as nocisensors.
Explain the types of pain experienced in terms of A delta and C fibres
- Initially, A delta are the first fibres to be activated upon a painful stimulus. Thus, patients feel a very sharp pain (as A delta fibres transmit pain very fast due to their myelination)
- Eventually, the pain stimulus is transferred to C fibres, and this is when the patient will experience the onset of dull pain
Describe how the pain scale works
- VAS numeric pain distress scale works by getting patients to describe their pain on a scale from 1 to 10
- This helps guide clinicians to prescribe analgesics accordingly
State the signs of inflammation
- Calor (heat)
- Tumour (swelling, oedema)
- Rubor (redness, erythema)
- Dolor (pain)
Explain the mechanism of inflammatory of pain
- The endothelial lining of capillaries/ the venous system contract upon the presence of an inflammatory stimuli
- This allows molecules such as leukocytes, to enter the peripheral inflammatory tissue. Under normal circumstances, these cells should not be in peripheral tissue
- These molecules form inflammatory millieu at the site, and this may activate the peripheral nociceptors
Explain the COX 1 and COX 2 pathway, and how it leads to inflammatory pain
- In inflamed tissue, COX 2 production is upregulated (in normal circumstances, this does not happen. In normal tissue, only COX 1 is mainly being produced)
- Both enzymes produce prostaglandins that promote inflammation, pain, and fever; howeverCOX-1produces prostaglandins that activate platelets and protect the stomach and intestinal lining (essential for homeostasis)
- COX 2 catalyses the production of prostaglandins, such as PGE2 which activates nociceptive afferents, causing pain
List some examples of NSAIDS and their MOA (3)
- Aspirin: binds to COX 1. This can leads to loss of the lining of the stomach. Thus it is not used very much.
- Ibuprofen: Higher affinity to COX 2.
- Naproxen
List the side effects of Aspirin
- GI irritation (nausea, vomiting, gastric bleeding, heartburn, ulcers)
- Acid-Base/ electrolyte disturbances
- Causes hyperventilation
- Blood dyscrasia (blood disorders) and anaemia
- Allergic reactions
Describe specific COX 2 inhibitors - COXIBS
- These drugs are specific COX-2 inhibitors; Celecoxib, is used against rheumatoid arthritis and osteoarthritis
- They have analgesic, anti-pyretic and anti-inflammatory effects
- However, some COXIBs (like Rofecoxib) lower the amount of PGs that inhibit clot formation via platelet aggregation
- So as a side effect, they result in thrombosis and myocardial infarction
- A number of specific COX-2 inhibitors have been withdrawn from the market because of this adverse effect
Describe how bradykinin becomes a part of the inflammatory milieu and how it leads to pain
- When the endothelial cells contract, the molecule cofactor XII also enters the inflamed tissue
- Factor XII gets in touch with the collagen in the inflamed tissue and is converted into factor XIIa
- Factor XIIa then facilitates the conversion of prekallikrein into kallikrein
- Kallikrein then helps convert kininogen into bradykinin
- Bradykinin activates primary afferent nociceptors
- Thus stopping the production of bradykinin can help reduce the pain
Explain the role of nerve growth factor and BDNF in pain production
- Primary nociceptive afferents have receptors on their surface called tyrosine kinase A (TrKA)
- Nerve growth factors binds to the TrKA, eventually forming a dimer
- This dimer goes into a vesicle, and this is transported from the peripheral tissue to the dorsal ganglion where the primary nociceptive afferent bodies are
- Then, through a molecular cascade, it will change gene expression which will sensitise receptors, thus causing hyperalgesia
- Brain derived neurotrophic factor (BDNF) is one of the molecules that are upregulated. BDNF and glutamate activate secondary neurones, thus activating pain conduction
- Thus, targeting NGF can help reduce pain by inhibiting the above pathways
Describe the role of NMDA receptors in pain conduction and hypersensitivity of 2nd order neurones
- Primary afferents are activated by noxious stimuli (action potential). This causes the release of glutamate
- Glutamate will bind to the NDMA and AMPA receptors on the post synaptic neurone
- This causes activation of the receptors, opening up their ion channels. Na will enter into the AMPA receptor. It will not enter the NMDA receptor immediately as the NMDA receptor will be blocked by Mg ions
- Thus constant entry of Na will change the voltage to -20mv which will cause Mg to unbind from the NMDA receptor
- Na and Ca can begin entering from the NMDA receptor
- Once Ca begins entering into the NMDA receptor, it will cause 2nd order neurones to be in a constant, active state (hypersensitivity).
- Hence, even a small signal from first order neurones will cause excitability of 2nd order neurones
Describe how ketamine works to block pain conduction
- Ketamine will bind to NMDA receptors and remain there even if Mg falls off
- Thus, it will not allow Na, and thus Ca to enter the neurone
- Holistically, it will prevent long-term potentiation
Describe why cocaine is not a good local anaesthetic, and why lidocaine is a good local anaesthetic
- Cocaine’s molecular structure is ester linked
- Plasma cholinesterase’s readily cleave this ester link, causing swift deactivation of cocaine’s analgesic effects
- Lidocaine is a good anaesthetic because it has amide links, which is not easily cleaved by the body
Describe how local anaesthetics (LA) work
- LA molecules penetrates through the phospholipid bilayer of the neurone and goes into the cytoplasm (does not reside in extracellular area)
- From the cytoplasm, the LA molecule will travel up to voltage gated Na channels and block it from the inside
- Thus, the voltage gated Na channel goes into an inactivation state, where its inactivation gate closes the channel off.
- Then, it will go back to its open state briefly, but since the lidocaine is still blocking the channel, it will eventually go into a closed state
- If action potentials (pain signals) keep coming in, the lidocaine molecule will remain sitting in the pore. In addition, more lidocaine molecules will block more pores. It is a positive feedback loop
- However if no action potentials are coming for some time, lidocaine will fall out.